English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

MPS-Authors
/persons/resource/persons15994

Watanabe,  T.
Biomedical NMR Research GmbH, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15082

Frahm,  J.
Biomedical NMR Research GmbH, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)

3029820_Suppl_1.htm
(Supplementary material), 446KB

3029820_Suppl_2.pdf
(Supplementary material), 123KB

Citation

Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., et al. (2019). β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature, 566, 503-508. doi:10.1038/s41586-019-0964-2.


Cite as: https://hdl.handle.net/21.11116/0000-0003-0FAB-D
Abstract
The grey matter is a central target of pathological processes in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. The grey matter is often also affected in multiple sclerosis, an autoimmune disease of the central nervous system. The mechanisms that underlie grey matter inflammation and degeneration in multiple sclerosis are not well understood. Here we show that, in Lewis rats, T cells directed against the neuronal protein β-synuclein specifically invade the grey matter and that this is accompanied by the presentation of multifaceted clinical disease. The expression pattern of β-synuclein induces the local activation of these T cells and, therefore, determined inflammatory priming of the tissue and targeted recruitment of immune cells. The resulting inflammation led to significant changes in the grey matter, which ranged from gliosis and neuronal destruction to brain atrophy. In humans, β-synuclein-specific T cells were enriched in patients with chronic-progressive multiple sclerosis. These findings reveal a previously unrecognized role of β-synuclein in provoking T-cell-mediated pathology of the central nervous system.